FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100057221> ?p ?o ?g. }

• W2100057221 endingPage "296" @default.
• W2100057221 startingPage "285" @default.
• W2100057221 abstract "1. The present survey is dealing with the interactions between the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS) in various organs and tissues, with an emphasis on the angiotensin AT-receptors located at the sympathetic nerve endings. 2. Angiotensin II, the main effector of the RAAS is known to stimulate sympathetic nerve traffic and its sequelae in numerous organs and tissues, such as the central nervous system, the adrenal medulla, the sympathetic ganglia and the sympathetic nerve endings. These stimulatory effects are mediated by AT(1)-receptors and counteracted by AT(1)-receptor antagonists. 3. Sympatho-inhibition at the level of the sympathetic nerve ending appears to be a class effect of the AT(1)-receptor blockers, mediated by presynaptic AT(1)-receptors. With respect to the ratio pre-/postsynaptic AT(1)-receptor antagonism important quantitative differences between the various compounds were found. 4. Both the pre- and postjunctional receptors at the sympathetic nerve endings belong to the AT(1)-receptor population. However, the presynaptic receptors belong to the AT(1B)-subtype, whereas the postjunctional receptors probably belong to a different AT(1)-receptor subpopulation. 5. Sympatho-inhibition is a class effect of the AT(1)-receptor antagonists. In conditions in which the SNS plays a pathophysiological role, such as hypertension and congestive heart failure, this property may well be of therapeutic relevance." @default.
• W2100057221 created "2016-06-24" @default.
• W2100057221 creator A5015640331 @default.
• W2100057221 creator A5022633390 @default.
• W2100057221 creator A5050545256 @default.
• W2100057221 creator A5079535874 @default.
• W2100057221 date "2003-10-01" @default.
• W2100057221 modified "2023-09-24" @default.
• W2100057221 title "AT₁‐receptor blockade and sympathetic neurotransmission in cardiovascular disease" @default.
• W2100057221 cites W143205812 @default.
• W2100057221 cites W1603366872 @default.
• W2100057221 cites W1966397067 @default.
• W2100057221 cites W1967340565 @default.
• W2100057221 cites W1970724100 @default.
• W2100057221 cites W1973322174 @default.
• W2100057221 cites W1974913171 @default.
• W2100057221 cites W1981598423 @default.
• W2100057221 cites W1984963533 @default.
• W2100057221 cites W1989736954 @default.
• W2100057221 cites W1997062534 @default.
• W2100057221 cites W1997583055 @default.
• W2100057221 cites W1999229604 @default.
• W2100057221 cites W1999502241 @default.
• W2100057221 cites W2000579941 @default.
• W2100057221 cites W2001880687 @default.
• W2100057221 cites W2007866347 @default.
• W2100057221 cites W2009059313 @default.
• W2100057221 cites W2009172018 @default.
• W2100057221 cites W2011909010 @default.
• W2100057221 cites W2012074143 @default.
• W2100057221 cites W2012843572 @default.
• W2100057221 cites W2013020664 @default.
• W2100057221 cites W2017558893 @default.
• W2100057221 cites W2017827603 @default.
• W2100057221 cites W2018433250 @default.
• W2100057221 cites W2022880294 @default.
• W2100057221 cites W2024386716 @default.
• W2100057221 cites W2029372749 @default.
• W2100057221 cites W2033639076 @default.
• W2100057221 cites W2035126585 @default.
• W2100057221 cites W2037816254 @default.
• W2100057221 cites W2038273677 @default.
• W2100057221 cites W2038329905 @default.
• W2100057221 cites W2038480284 @default.
• W2100057221 cites W2039377412 @default.
• W2100057221 cites W2041105413 @default.
• W2100057221 cites W2043343137 @default.
• W2100057221 cites W2050809323 @default.
• W2100057221 cites W2050947502 @default.
• W2100057221 cites W2051868585 @default.
• W2100057221 cites W2054323238 @default.
• W2100057221 cites W2054635454 @default.
• W2100057221 cites W2055370859 @default.
• W2100057221 cites W2055855401 @default.
• W2100057221 cites W2056893352 @default.
• W2100057221 cites W2059277101 @default.
• W2100057221 cites W2063647162 @default.
• W2100057221 cites W2075580596 @default.
• W2100057221 cites W2086033446 @default.
• W2100057221 cites W2092171289 @default.
• W2100057221 cites W2094195778 @default.
• W2100057221 cites W2095597358 @default.
• W2100057221 cites W2096583106 @default.
• W2100057221 cites W2109896298 @default.
• W2100057221 cites W2130393909 @default.
• W2100057221 cites W2130575832 @default.
• W2100057221 cites W2135038122 @default.
• W2100057221 cites W2139045354 @default.
• W2100057221 cites W2140595638 @default.
• W2100057221 cites W2143540423 @default.
• W2100057221 cites W2143574741 @default.
• W2100057221 cites W2146199771 @default.
• W2100057221 cites W2154885779 @default.
• W2100057221 cites W2165133614 @default.
• W2100057221 cites W2168907840 @default.
• W2100057221 cites W2305593797 @default.
• W2100057221 cites W2313416023 @default.
• W2100057221 cites W2314802508 @default.
• W2100057221 cites W2316252676 @default.
• W2100057221 cites W2321056299 @default.
• W2100057221 cites W2322154929 @default.
• W2100057221 cites W2322513013 @default.
• W2100057221 cites W2330476365 @default.
• W2100057221 cites W2400581518 @default.
• W2100057221 cites W2438135878 @default.
• W2100057221 cites W635881744 @default.
• W2100057221 doi "https://doi.org/10.1111/j.1474-8673.2004.00301.x" @default.
• W2100057221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15255813" @default.
• W2100057221 hasPublicationYear "2003" @default.
• W2100057221 type Work @default.
• W2100057221 sameAs 2100057221 @default.
• W2100057221 citedByCount "31" @default.
• W2100057221 countsByYear W21000572212013 @default.
• W2100057221 countsByYear W21000572212014 @default.
• W2100057221 countsByYear W21000572212015 @default.
• W2100057221 countsByYear W21000572212016 @default.
• W2100057221 countsByYear W21000572212018 @default.
• W2100057221 countsByYear W21000572212019 @default.

• next